Alaunos Therapeutics
TCRT
TCRT
82 hedge funds and large institutions have $2.97M invested in Alaunos Therapeutics in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 25 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
60% less capital invested
Capital invested by funds: $7.36M → $2.97M (-$4.39M)
60% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 25
Holders
82
Holding in Top 10
–
Calls
$20K
Puts
$2K
Top Buyers
| 1 | +$31.6K | |
| 2 | +$27K | |
| 3 | +$11.5K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$9.45K |
| 5 |
Millennium Management
New York
|
+$7.12K |
Top Sellers
| 1 | -$810K | |
| 2 | -$145K | |
| 3 | -$115K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$75K |
| 5 |
Two Sigma Advisers
New York
|
-$27.9K |